Objective Systemic sclerosis (SSc) is a multisystemic autoimmune disease with high morbidity and healthcare costs. Inconsistent quality of care delivery, including inadequate screening and monitoring,...

We are excited to announce the launch of Schroeder Arthritis Institute’s Arthritis Rounds! These will feature clinical case discussion that provide insights into the diagnosis and management of comp...

Disease screening aims to identify individuals at risk for specific conditions. It is expected that an early detection allows for early intervention, with improved outcomes. However, large scale screening programs may not only have implications on resources, patient outcomes may not improve but may worsen if screening for the targeted disease has not been carefully designed and executed. On the other hand, a gradience in association between the measured value in health assessment and future risks of diseases may exist for many measures such as body weight, blood pressure, and biochemical test results.

This viewpoint examines the use of generative AI (genAI) models in medical writing, discusses the opportunities and threats they represent, and highlights avenues for improvement and future research.